Vivaldi Biosciences

 

 

 

Archived News Releases


Vivaldi Biosciences News Releases

 

01/21/14 | Vivaldi Biosciences Signs Cooperative Research and Development Agreement (CRADA) with National Institute of Allergy and Infectious Diseases (NIAID) to Develop Live Attenuated Influenza Vaccine Against Influenza H7N9
10/10/13 | Vivaldi Biosciences Acquires Clinical-Stage Influenza Vaccine Assets
10/05/09 | Vivaldi Biosciences Announces Issuance of US Patent for Influenza Vaccines
02/25/09 | Vivaldi Biosciences Announces the Appointment of William Wainwright, PhD as Vice President, Vaccine Development
01/08/09 | Vivaldi Biosciences Enters into Agreements for $23 Million in Series A Financing
   
   

 

 

 

 

   
 


Website Design and website updates by LoneTree Web Studio, Brentwood, CA

Home | About | Management Team | Board of Directors | Scientific Advisors | Product Development | Publications | News and Events | Contact